High-risk KPC-producing Klebsiella pneumoniae lack type I R-M systems

Ying Zhou,Dongxing Tian,Yu Tang,Lianhua Yu,Yunkun Huang,Gang Li,Meng Li,Yong Wang,Zehua Yang,Laurent Poirel,Xiaofei Jiang
DOI: https://doi.org/10.1016/j.ijantimicag.2020.106050
IF: 15.441
2020-08-01
International Journal of Antimicrobial Agents
Abstract:<p><em>Klebsiella pneumoniae</em> carbapenemase (KPC)-producing <em>K. pneumoniae</em> (KPC-KP) have disseminated worldwide and are a major threat to public health. The multidrug-resistant (MDR)-phenotype of KPC-KP are commonly associated with the presence of high molecular weight <em>bla</em><sub>KPC</sub> plasmids. Restriction-modification (R-M) systems provide bacteria with innate defense against plasmids or other infectious gene elements. As <em>bla</em><sub>KPC</sub> plasmids are favored by such MDR <em>K. pneumoniae,</em> it was of interest to examine the co-distribution of R-M and acquired <em>bla</em><sub>KPC</sub> plasmids in KPC-KP. A total of 459 clinical <em>K. pneumoniae</em> isolates in China and 217 global whole-genome sequences in GenBank were collected to determine the prevalence of type I R-M systems. The type I R-M systems were scarce in the KPC-positive group and high-risk <em>Klebsiella pneumoniae</em> clonal group 258 (CG258). The polymorphisms of type I R-M observed in <em>K. pneumoniae</em> revealed the ubiquity of their recognition sequences in DNA; therefore, the type I R-M systems could attack most invading DNA elements, such as <em>bla</em><sub>KPC</sub> genes. Overall, this work indicated the type I R-M systems may impact the acquisition of <em>bla</em><sub>KPC</sub> genes in <em>K. pneumoniae</em>.</p>
pharmacology & pharmacy,infectious diseases,microbiology
What problem does this paper attempt to address?